Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-23-014592

SVP, Chief Scientific Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BELVIN MARCIA · SVP, Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-22 Grant or award : show line 1 in the form +60,000 140,820 D
Loading xslF345X04/form4.xml…